Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,630 shares at $398.25 ($647K) on 2020-10-15, disclosed to the SEC on 2020-10-19.
Open-market sale of $647k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $391.48 | 42 | $16K | 2.5% |
| 2 | $395.02 | 120 | $47K | 7.3% |
| 3 | $396.51 | 255 | $101K | 15.6% |
| 4 | $396.51 | 255 | $101K | 15.6% |
| 5 | $397.41 | 375 | $149K | 23.0% |
| 6 | $397.41 | 375 |
| $149K |
| 23.0% |
| 7 | $398.25 | 208 | $83K | 12.8% |
| Total | $396.91 avg | 1,630 | $647K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |